Description of the Business
Anpario is an international producer and distributor of high performance natural feed additives for animal health, hygiene and nutrition. Anpario’s expertise is focused on intestinal health and nutrition and utilizing this understanding to improve animal performance and producer profitability.
Anpario supplies its customers with quality assured products manufactured in the United Kingdom and has an established global sales and distribution network in over 70 countries, which includes a number of wholly owned subsidiaries in the key markets around the world.
Anpario is listed on the London Stock Exchange’s AIM market and was built up from a combination of three UK companies: Meriden Animal Health, Kiotechagil and Optivite. Since these acquisitions, Anpario has made gradual internal changes to combine and standardise systems and processes, to form one company under the Anpario brand.
These changes have brought together cutting-edge product technologies and the broadest range of speciality feed additive products in the market, including pioneering products such as ‘Orego-Stim’ and ‘Salkil’. In addition to the company’s gut health and nutritional expertise, Anpario is uniquely able to apply special active ingredients to a carrier matrix system. Anpario’s primary objective is to deliver greater outputs from the limited global resources in an efficient and sustainable way. The benefits of our products have not only demonstrated their value to the animals that have been fed our feed additives, but also to the progeny that they produce.
Our expertise has been developed over many years and we now work with key research sites and universities across the world when developing our product technology. The portfolio of innovative products is divided into four categories: Eubiotics, Feed Security, Feed Quality and Nutritional. Products are packaged in bespoke high quality packs and colour coded by category for ease of identification by our customers.
Names, Responsibilities and Biographies of the Directors
Peter Lawrence, Non-Executive Chairman
Peter joined the Board in August 2005 as a Non-Executive Director and became Non- Executive Chairman in 2017. Peter founded ECO Animal Health Group plc where he was Non-Executive Chairman having been an Executive Director ever since its formation in 1972. Peter is the Non-Executive Chairman of Baronsmead Venture Trust plc and Amati AIM VCT plc.
Peter became Non-Executive Chairman in 2017.
Richard Wood, Senior Independent Director
Richard joined the Board in November 2017 as a Senior Independent Director. Richard has considerable global animal health experience having built Genus plc from a small company privatised by the government, into a world leading animal genetics company.
His past appointments include Non-Executive and Senior Independent Director of Avon Rubber plc and Chairman at ECO Animal Health Group plc, Ocean Harvest Technology Inc., Atlantic Pharmaceuticals plc, Innovis (a sheep genetics company) and Silent Herdsman Limited (Farming Technology).
Richard Edwards, Chief Executive Officer
Richard Edwards joined the Board in December 2006 as Chief Executive following the acquisition of Agil. He was appointed Executive Vice-Chairman in April 2011 with specific responsibility for implementing acquisition strategy. In January 2016, Richard was re-appointed to the position of CEO.
Richard has extensive general management and corporate strategy experience gained in the sales and distribution sector both in the UK and internationally. Previously he was Director and General Manager of WF Electrical, a £140 million turnover division of Hagemeyer (UK) plc, a distributor of industrial products, and gained significant experience in corporate development at Saint Gobains UK building materials business.
Karen Prior, Group Finance Director
Karen joined the board in October 2009 as Group Finance Director. Previously, Karen had roles as Finance Director of Town Centre Securities PLC, a listed property group and UK Finance Director of Q-Park, where she was instrumental in its establishment and growth in the UK.
Karen was also Financial Controller of train builders Bombardier Transportation and spent 10 years of her early career with Ernst and Young specialising in providing audit and business services to entrepreneurial businesses.
Committees of the Board of Directors
Peter Lawrence – Chairman
Richard Wood – Chairman
Peter Lawrence – Chairman
Country of incorporation and main country of operation
Registered in England and Wales number 03345857
Main country of operation is England
Current Constitutional Documents
Certificate of Incorporation – Kiotech International plc
Certificate of Incorporation – Change of Name to Anpario plc
Articles of Association adopted 01-Oct-2010
Number of AIM Securities in Issue
The total number of ordinary shares in issue (excluding shares held as treasury shares) is 23,310,173.
Updated 21st June 2019
AIM Securities not in public hands
Updated 21st June 2019
Identity and percentage of holdings of significant shareholders
Shareholder Ordinary Shares 000′ % Held Royal Trust Corp of Canada Custodians 2,750 11.8 Investec Wealth & Investment Limited 2,332 10.0 Unicorn Asset Management Limited 2,046 8.8 Gresham House Asset Management Limited 1,399 6.0 Downing LLP 1,119 4.8 Allianz Global Investors GmbH 1,100 4.7 Schroder Investment 804 3.4 Miton Group plc 761 3.3 Hargreaves Lansdown Asset Mgt 739 3.2
Updated 05th November 2019
Details of any restrictions on the transfer of AIM Securities
There are no restrictions on the transfer of securities.
Anpario plc is not listed on any other exchanges or trading platforms.
Anpario plc is subject to the UK City Code on Takeovers and Mergers.
- Recent Financial reports
- Notifications made by Anpario plc
- Details of admission documents
Details of the nominated advisers and key advisers
Nominated Advisor & Broker:
Peel Hunt LLP
120 London Wall,
Tel: +44 (0) 207 418 8900
Chartered Accountants and Statutory Auditors,
1 City Square
Share Registrars Limited
17 West Street,
Tel: +44 (0) 1252 821390
Fax: +44 (0) 1252 719232
The above information has been disclosed pursuant to Rule 26 of the AIM Rules for Companies.
Details of the corporate governance code that the AIM Company has decided to apply
The Directors recognise the value and importance of high standards of corporate governance and intend, where practicable given the Company’s size and the constitution of the Board, to comply with appropriate standards. Anpario has chosen to apply the Quoted Companies Alliance Corporate Governance Code (“QCA Code”) further information is available in the Corporate Governance statement available from https://www.anpario.com/investor/corporate-governance/